Current Topics in Microbiology and Immunology (1993) Volume on Adhesion in Leukocyte Homing and Differentiation (eds D. Dunon, C. R. Mackay, and B. A. Imhof) CD44: a multitude of isoforms with diverse functions
暂无分享,去创建一个
[1] P. Grabowski,et al. Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. , 1991, Science.
[2] N. Fusenig,et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. , 1987, Oncogene.
[3] W. Carter,et al. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.
[4] L. Picker,et al. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.
[5] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[6] J. Hornung,et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.
[7] J. R. de los Toyos,et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.
[8] S. Jalkanen,et al. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.
[9] J. Bell,et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] William,et al. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.
[11] M. Zöller,et al. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. , 1989, Cancer research.
[12] G. Nicolson,et al. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. , 1987, Cancer research.
[13] M. Wiles,et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.
[14] H. Liao,et al. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. , 1991, Cancer cells.
[15] C. Nottenburg,et al. Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Amiot,et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.
[17] P. Herrlich,et al. Retardation of metastatic tumor growth after immunization with metastasis‐specific monoclonal antibodies , 1990, International journal of cancer.
[18] R. Abe,et al. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. , 1991, Journal of immunology.
[19] A. Hart,et al. Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. , 1992, Oncogene.
[20] E. Puré,et al. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages , 1991, The Journal of cell biology.
[21] G. Bepler,et al. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. , 1988, Differentiation; research in biological diversity.
[22] M. Zöller,et al. Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. , 1983, Invasion & metastasis.
[23] A. Datta,et al. The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44. , 1992, Biochemical and biophysical research communications.
[24] S. Holland,et al. The cDNA sequence of mouse Pgp-1 and homology to human CD44 cell surface antigen and proteoglycan core/link proteins. , 1990, The Journal of biological chemistry.
[25] I. Stamenkovic,et al. Distinct effects of two CD44 isoforms on tumor growth in vivo , 1991, The Journal of experimental medicine.
[26] P. Frost,et al. Clinical implications of metastatic process , 1992, The Lancet.
[27] W. Carter,et al. Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Oshimura,et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. , 1992, Cancer research.
[29] Q. He,et al. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody , 1992, The Journal of experimental medicine.
[30] E. Butcher,et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.
[31] R. Akeson,et al. At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development , 1991, Molecular and cellular biology.
[32] P. Herrlich,et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.
[33] I. Stamenkovic,et al. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein , 1992, The Journal of experimental medicine.
[34] I. Stamenkovic,et al. CD44H regulates tumor cell migration on hyaluronate-coated substrate , 1992, The Journal of cell biology.
[35] C. Isacke,et al. Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. , 1992, The EMBO journal.
[36] P. Herrlich,et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. , 1991, Cancer research.
[37] P. Y. Chou,et al. Prediction of protein conformation. , 1974, Biochemistry.
[38] T. Hardingham,et al. Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] W. Carter,et al. Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[40] Brian Seed,et al. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.
[41] M. Mareel,et al. Tumour invasion: effects of cell adhesion and motility. , 1992, Trends in cell biology.
[42] N. Isola,et al. The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. , 1991, Biochemical and biophysical research communications.
[43] K. Miyake,et al. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.
[44] M. Telen,et al. CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.
[45] D. Tarin,et al. Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.
[46] C. Mackay,et al. Expression and modulation of CD44 variant isoforms in humans , 1994, The Journal of cell biology.
[47] J. Bishop,et al. Expression of CD44 is repressed in neuroblastoma cells , 1991, Molecular and cellular biology.
[48] J. Bell,et al. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. , 1992, The Journal of biological chemistry.
[49] T. Maniatis,et al. Mechanisms of alternative pre-mRNA splicing. , 1991, Science.
[50] D. Goeddel,et al. Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. , 1989, Journal of immunology.
[51] P. Goodfellow,et al. The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11 , 1982, European journal of immunology.
[52] B. Imhof,et al. Embryonic Colonization of the Thymus by T Cell Progenitors as a Model for Metastasis , 1992 .
[53] S. Jalkanen,et al. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. , 1988, Journal of immunology.
[54] C. June,et al. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. , 1990, Journal of immunology.
[55] P. Herrlich,et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.
[56] C. Underhill,et al. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells , 1989, The Journal of cell biology.
[57] L. Picker,et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.
[58] K. Ishihara,et al. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition , 1992, The Journal of cell biology.
[59] R. Humphries,et al. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells , 1991, The Journal of experimental medicine.
[60] Tae H. Lee,et al. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 , 1992, The Journal of cell biology.
[61] I. Hart,et al. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. , 1991, Cancer research.
[62] I. Hart,et al. Biology of tumour metastasis , 1992, The Lancet.
[63] R. Hynes,et al. In vitro splicing of fibronectin pre-mRNAs. , 1990, Nucleic Acids Research.
[64] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.